Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Steven Hayle. (2018) A tale of two Canadian cities: Comparing supervised consumption site (SCS) policy making in Toronto and Vancouver. Drugs: Education, Prevention and Policy 25:5, pages 397-407.
Read now
Read now
Sean A. Kidd, Helen Kirkpatrick & Lindsey George. (2011) Getting to know Mark, a homeless alcohol-dependent artist, as he finds his way out of the river. Addiction Research & Theory 19:2, pages 102-111.
Read now
Read now
M.E. Epele & M. Pecheny. (2007) Harm reduction policies in Argentina: A critical view. Global Public Health 2:4, pages 342-358.
Read now
Read now
Lee
Garth Vigilant. (2005) “I Don't Have Another Run Left With It”: Ontological Security in Illness Narratives of Recovering on Methadone Maintenance. Deviant Behavior 26:5, pages 399-416.
Read now
Read now
Laurie Dickson, Jeffrey L. Derevensky & Rina Gupta. (2004) Youth gambling problems: A harm reduction prevention model. Addiction Research & Theory 12:4, pages 305-316.
Read now
Read now
David Gurwitz. (1999) The therapeutic potential of nicotine and nicotinic agonists for weight control. Expert Opinion on Investigational Drugs 8:6, pages 747-760.
Read now
Read now
Articles from other publishers (25)
Marie Jauffret-Roustide & Marie Debrus. (2022) Co-production des savoirs sur l’usage de drogues et réduction des injustices épistémiques. Déviance et Société Vol. 47:1, pages 3-34.
Crossref
Crossref
Mark Lucherini, Sarah Hill & Katherine Smith. (2020) Inequalities, harm reduction and non-combustible nicotine products: a meta-ethnography of qualitative evidence. BMC Public Health 20:1.
Crossref
Crossref
Mark Lucherini, Sarah Hill & Katherine Smith. (2019) Potential for non-combustible nicotine products to reduce socioeconomic inequalities in smoking: a systematic review and synthesis of best available evidence. BMC Public Health 19:1.
Crossref
Crossref
Pierre Chappard, Jean-Pierre Couteron & Alain Morel. 2019. Addictologie. Addictologie
25
44
.
Marie Jauffret-Roustide & Isabelle Cailbault. (2018) Drug consumption rooms: Comparing times, spaces and actors in issues of social acceptability in French public debate. International Journal of Drug Policy 56, pages 208-217.
Crossref
Crossref
Nancy Tamimi. 2018. Philosophies and Sociologies of Bioethics. Philosophies and Sociologies of Bioethics
127
147
.
Romain Paumier. (2018) Connaitre le bon moment et la bonne distance. Nouvelles pratiques sociales 29:1-2, pages 72-86.
Crossref
Crossref
Tsz Ho Kwan, Ngai Sze Wong & Shui Shan Lee. (2015) Participation dynamics of a cohort of drug users in a low-threshold methadone treatment programme. Harm Reduction Journal 12:1.
Crossref
Crossref
Marc T. Kiviniemi & Lynn T. Kozlowski. (2015) Deficiencies in public understanding about tobacco harm reduction: results from a United States national survey. Harm Reduction Journal 12:1.
Crossref
Crossref
Lynn T. Kozlowski. (2015) The truncation of moral reasoning on harm reduction by individuals and organizations. Addiction 110:7, pages 1070-1072.
Crossref
Crossref
Chloé Potier, Vincent Laprévote, Françoise Dubois-Arber, Olivier Cottencin & Benjamin Rolland. (2014) Supervised injection services: What has been demonstrated? A systematic literature review. Drug and Alcohol Dependence 145, pages 48-68.
Crossref
Crossref
Annette R. Kaufman, Darren Mays, Amber R. Koblitz & David B. Portnoy. (2014) Judgments, Awareness, and the Use of Snus Among Adults in the United States. Nicotine & Tobacco Research 16:10, pages 1404-1408.
Crossref
Crossref
Andrew D. Hathaway. 2014. The Encyclopedia of Theoretical Criminology. The Encyclopedia of Theoretical Criminology
1
5
.
Helen Keane. (2013) Making smokers different with nicotine: NRT and quitting. International Journal of Drug Policy 24:3, pages 189-195.
Crossref
Crossref
Catriona Rooke. (2012) Harm reduction and the medicalisation of tobacco use. Sociology of Health & Illness 35:3, pages 361-376.
Crossref
Crossref
Marie Jauffret-Roustide & Pierre Chappard. 2012. L'aide-mémoire de la réduction des risques en addictologie. L'aide-mémoire de la réduction des risques en addictologie
38
46
.
Jemell Geraghty. (2011) Drug policy, intravenous drug use, and heroin addiction in the UK. British Journal of Nursing 20:14, pages 878-884.
Crossref
Crossref
Olaf Aasland, Guri Spilhaug*Arne Johannesen. (2009) Fastlegers syn på legemiddelassistert rehabilitering og rusreformen. Tidsskrift for Den norske legeforening 129:2, pages 97-100.
Crossref
Crossref
John L. Fitzgerald. (2016) The Australian National Council on Drugs (ANCD) and Governance in the Australian Drug Policy Arena. Contemporary Drug Problems 32:2, pages 259-293.
Crossref
Crossref
Icro Maremmani, Matteo Pacini, Giulio Perugi & Hagop S Akiskal. (2004) Addiction and the Bipolar Spectrum. Addictive Disorders & Their Treatment 3:4, pages 156-164.
Crossref
Crossref
Tuukka Tammi. (2018) The Harm-Reduction School of Thought: Three Fractions. Contemporary Drug Problems 31:3, pages 381-399.
Crossref
Crossref
Laurie M. Dickson, Jeffrey L. Derevensky & Rina Gupta. (2016) Harm Reduction for the Prevention of Youth Gambling Problems. Journal of Adolescent Research 19:2, pages 233-263.
Crossref
Crossref
Pebbles FaganGary KingDeirdre LawrenceSallie Anne PetrucciRobert G. RobinsonDavid BanksSharon MarableRachel Grana. (2004) Eliminating Tobacco-Related Health Disparities: Directions for Future Research. American Journal of Public Health 94:2, pages 211-217.
Crossref
Crossref
Amy FairchildJames Colgrove. (2004) Out of the Ashes: The Life, Death, and Rebirth of the “Safer” Cigarette in the United States. American Journal of Public Health 94:2, pages 192-204.
Crossref
Crossref
B. Ann Hilton, Ray Thompson, Laura Moore‐Dempsey & Randy G. Janzen. (2008) Harm reduction theories and strategies for control of human immunodeficiency virus: a review of the literature. Journal of Advanced Nursing 33:3, pages 357-370.
Crossref
Crossref